BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4359681)

  • 1. Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin).
    Tagaya I; Nakao C; Hara M; Yamadera S
    Bull World Health Organ; 1973 May; 48(5):547-54. PubMed ID: 4359681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
    Minor PD
    J Gen Virol; 1982 Apr; 59(Pt 2):307-17. PubMed ID: 6281371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliomyelitis in Japan during the period 1962-68 after the introduction of mass vaccination with Sabin vaccine.
    Takatsu T; Tagaya I; Hirayama M
    Bull World Health Organ; 1973; 49(2):129-37. PubMed ID: 4545320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Poliomyelitis situation in Madagascar in 1993. Several considerations about the role of the laboratory in the eradication strategy].
    Morvan JM
    Arch Inst Pasteur Madagascar; 1993; 60(1-2):14-9. PubMed ID: 7910726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.
    Melnick JL; Berencsi G; Biberi-Moroeanu S; Combiescu AA; Furesz J; Kantoch M; Kostrzewski J; Magrath DI; Perkins FT; Vonka V; Cockburn WC; Dömök I; Assaad FA
    Bull World Health Organ; 1972; 47(3):287-94. PubMed ID: 4346582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratypic characterization of poliovirus type 1 isolates.
    Deshpande JM; Dave KH
    Indian J Med Res; 1991 Jul; 93():202-7. PubMed ID: 1660032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratypic serodifferentiation of poliovirus type 1 strains isolated during outbreaks of paralytic poliomyelitis.
    Deshpande JM; Dave KH
    Indian J Med Res; 1988 Feb; 87():103-7. PubMed ID: 2840388
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic and biochemical characterization of poliovirus type 1 isolates.
    Hara M; Arita M; Yamazaki Z; Hagiwara A; Saito Y
    Microbiol Immunol; 1987; 31(4):327-36. PubMed ID: 3039316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliomyelitis survey in Middle-East countries.
    Brigaud M; Aymard M; Thouvenot D; Chomel JJ; Mahmood RA; Mathew PP; Jafar AK
    Dev Biol Stand; 1978; 41():149-58. PubMed ID: 223907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera.
    van Wezel AL; Hazendonk AG
    Intervirology; 1979; 11(1):2-8. PubMed ID: 218891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin.
    Hara M; Hagiwara A; Yoneyama T; Saito Y; Shimojo H
    Microbiol Immunol; 1983; 27(12):1057-65. PubMed ID: 6328228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of monoclonal antibodies for the intratypic differentiation of strains of poliomyelitis type I virus].
    Lashkevich VA; Mustafina AN; Koroleva GA; Gracheva LA; Grishina KG
    Vopr Virusol; 1987; 32(2):183-8. PubMed ID: 2440185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain characterization studies of poliovirus type I isolates from poliomyelitis cases in the United States in 1979.
    Hatch MH; Marchetti GE; Nottay BK; Kew OM; Heyward JT; Obijeski JF
    Dev Biol Stand; 1981; 47():307-15. PubMed ID: 6262156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratypic differentiation of poliovirus strains isolated from sewage: consequences for the practise of oral vaccination].
    Kuwert E; Höher PG; Primavesi CA
    Zentralbl Bakteriol Orig; 1970; 215(1):16-25. PubMed ID: 4321148
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.